Director, Mark S. Humayun MD, PhD, devoted his career to developing treatments for eye diseases, after having watched his grandmother lose her vision to diabetes. But discovering cures for vision loss is no easy feat, as visual processing involves both the complex machinery of the eye, and approximately 30% of the cerebral cortex of the brain. Through the development of vision restoration treatments, a strong foundation has been built upon which USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics (IBT) can expand, allowing the creation of a new generation of therapies that target debilitating neurosensory diseases.